Phibro Animal Health (PAHC) Assets (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Assets came in at $1.4 billion in Q1 2026, up 9.71% year-on-year from $1.3 billion in Q1 2025, and up 2.81% quarter-over-quarter from $1.4 billion in Q4 2025.
Phibro Animal Health (PAHC) Assets (2013 - 2026) Analysis & Trends
Phibro Animal Health's Assets history runs 14 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- On a quarterly basis, Assets rose 9.71% year-over-year to $1.4 billion in Q1 2026; TTM through Mar 2026 was $1.4 billion, a 9.71% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, up 38.56% from the prior year.
- Assets rose to $1.4 billion in Q1 2026 per PAHC's latest filing, from $1.4 billion in the prior quarter.
- Across five years, Assets topped out at $1.4 billion in Q1 2026 and bottomed at $916.2 million in Q1 2022.
- The 5-year median for Assets is $972.7 million (2023), against an average of $1.1 billion.
- Across the five-year window, Assets gained 0.18% in 2024 and surged 43.39% in 2025, its largest moves.
- Year by year, Assets stood at $961.8 million in 2022, then advanced by 1.13% to $972.7 million in 2023, then soared by 32.16% to $1.3 billion in 2024, then gained by 9.34% to $1.4 billion in 2025, then advanced by 2.81% to $1.4 billion in 2026.
- Per Business Quant, the three latest PAHC Assets figures stand at $1.4 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.4 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 1.45 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.45 Bn |
| Dec 31, 2025 | 1.41 Bn |
| Sep 30, 2025 | 1.39 Bn |
| Jun 30, 2025 | 1.36 Bn |
| Mar 31, 2025 | 1.32 Bn |
| Dec 31, 2024 | 1.29 Bn |
| Sep 30, 2024 | 966.29 Mn |
| Jun 30, 2024 | 982.18 Mn |
| Mar 31, 2024 | 979.04 Mn |
| Dec 31, 2023 | 972.71 Mn |
| Sep 30, 2023 | 964.52 Mn |
| Jun 30, 2023 | 971.40 Mn |
| Mar 31, 2023 | 965.43 Mn |
| Dec 31, 2022 | 961.83 Mn |
| Sep 30, 2022 | 948.38 Mn |
| Jun 30, 2022 | 931.70 Mn |
| Mar 31, 2022 | 916.18 Mn |
| Dec 31, 2021 | 848.96 Mn |
| Sep 30, 2021 | 836.04 Mn |
| Jun 30, 2021 | 841.33 Mn |